相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu et al.
NATURE MEDICINE (2021)
Identification of PIKfyve kinase as a target in multiple myeloma
Cecilia Bonolo de Campos et al.
HAEMATOLOGICA (2020)
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
Emmanuel S. Antonarakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
Paola Ciciola et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy
Muhammad Zaeem Noman et al.
SCIENCE ADVANCES (2020)
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I
Keisuke Yamamoto et al.
NATURE (2020)
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development
Nallasivam Palanisamy et al.
CLINICAL CANCER RESEARCH (2020)
Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-resistant Prostate Cancer: A Phase I Study of Concurrent Enzalutamide and Crizotinib
Abhishek Tripathi et al.
CLINICAL CANCER RESEARCH (2020)
Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response
Laura Poillet-Perez et al.
NATURE CANCER (2020)
CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors
Emmanuel S. Antonarakis et al.
JCO PRECISION ONCOLOGY (2020)
A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis
Gaurav Sharma et al.
AUTOPHAGY (2019)
Clinical Features and Therapeutic Outcomes in Men with Advanced Prostate Cancer and DNA Mismatch Repair Gene Mutations
Emmanuel S. Antonarakis et al.
EUROPEAN UROLOGY (2019)
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
Wassim Abida et al.
JAMA ONCOLOGY (2019)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
Lysosome enlargement during inhibition of the lipid kinase PIKfyve proceeds through lysosome coalescence
Christopher H. Choy et al.
JOURNAL OF CELL SCIENCE (2018)
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney
Lisha Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Autophagy maintains tumour growth through circulating arginine
Laura Poillet-Perez et al.
NATURE (2018)
Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
Tomasz M. Beer et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner
Takouhie Mgrditchian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Leanne G. Ahronian et al.
GENOME MEDICINE (2017)
Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade
Inna Serganova et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition
Sophia Gayle et al.
AUTOPHAGY (2017)
Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma
Sophia Gayle et al.
BLOOD (2017)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
Holger Bronger et al.
BRITISH JOURNAL OF CANCER (2016)
Atg7 cooperates with Pten loss to drive prostate cancer tumor growth
Urmila Santanam et al.
GENES & DEVELOPMENT (2016)
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
Matthew Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
An Autophagic Flux Probe that Releases an Internal Control
Takeshi Kaizuka et al.
MOLECULAR CELL (2016)
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
Yuanyuan Qiao et al.
NEOPLASIA (2016)
An investigator-initiated phase I study of crizotinib in combination with enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) before or after progression on docetaxel.
Lauren Christine Harshman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
Farsad Afshinnia et al.
KIDNEY INTERNATIONAL REPORTS (2016)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
Phosphatidylethanolamine positively regulates autophagy and longevity
P. Rockenfeller et al.
CELL DEATH AND DIFFERENTIATION (2015)
Rph1/KDM4 Mediates Nutrient-Limitation Signaling that Leads to the Transcriptional Induction of Autophagy
Amelie Bernard et al.
CURRENT BIOLOGY (2015)
Autophagy: eat thyself, sustain thyself
Vivien Marx
NATURE METHODS (2015)
Identification of secreted proteins that reflect autophagy dynamics within tumor cells
Adam A. Kraya et al.
AUTOPHAGY (2015)
Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
R. Ferraldeschi et al.
ONCOGENE (2015)
Three-dimensional models of cancer for pharmacology and cancer cell biology: Capturing tumor complexity in vitro/ex vivo
John A. Hickman et al.
BIOTECHNOLOGY JOURNAL (2014)
An open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer
Roberto Pili et al.
INVESTIGATIONAL NEW DRUGS (2014)
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon et al.
LANCET ONCOLOGY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
H. G. Nguyen et al.
ONCOGENE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
David C. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
1L-23R is epigenetically regulated and modulated by chemotherapy in Non-Small Cell Lung Cancer
Anne-Marie Baird et al.
FRONTIERS IN ONCOLOGY (2013)
Tyrosine kinase signaling and the emergence of multicellularity
W. Todd Miller
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent
Robert L. Hudkins et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effect of dual inhibition of apoptosis and autophagy in prostate cancer
Ahamed Saleem et al.
PROSTATE (2012)
Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis
Huijun Wei et al.
GENES & DEVELOPMENT (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
The Role of Autophagy in Cancer: Therapeutic Implications
Zhineng J. Yang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The emerging role of CXCL10 in cancer (Review)
Mingli Liu et al.
ONCOLOGY LETTERS (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
Ville Harma et al.
PLOS ONE (2010)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
PIKfyve: Partners, significance, debates and paradoxes
Assia Shisheva
CELL BIOLOGY INTERNATIONAL (2008)
A selective PIKfyve inhibitor blocks PtdIns(3,5) P2 production and disrupts endomembrane transport and retroviral budding
Harold B. J. Jefferies et al.
EMBO REPORTS (2008)
Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo
Joji Nagasawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line
PA Watson et al.
CANCER RESEARCH (2005)
The Fab1 phosphatidylinositol kinase pathway in the regulation of vacuole morphology
JA Efe et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
分享论文
